These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32974431)

  • 21. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients.
    Milwidsky A; Frydman S; Laufer-Perl M; Sadeh B; Sapir O; Granot Y; Hochstadt A; Korotetski L; Ketchker L; Topilsky Y; Banai S; Havakuk O
    ESC Heart Fail; 2022 Apr; 9(2):1487-1491. PubMed ID: 35083882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.
    Benza RL; Doyle M; Lasorda D; Parikh KS; Correa-Jaque P; Badie N; Ginn G; Airhart S; Franco V; Kanwar MK; Murali S; Raina A; Agarwal R; Rajagopal S; White J; Biederman R
    Chest; 2019 Dec; 156(6):1176-1186. PubMed ID: 31265832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study.
    García-González MJ; de Mora-Martín M; López-Fernández S; López-Díaz J; Martínez-Sellés M; Romero-García J; Cordero M; Lara-Padrón A; Marrero-Rodríguez F; del Mar García-Saiz M; Aldea-Perona A;
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):573-9. PubMed ID: 23887741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new option for monitoring heart failure. First experience in Spain with CardioMEMS.
    Codina P; Altisent OA; Santiago-Vacas E; Domingo M; Lupón J; Bayes-Genis A
    Med Clin (Barc); 2021 Jan; 156(1):26-28. PubMed ID: 33059937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding adherence to the CardioMEMS pulmonary artery pressure monitoring system for heart failure: A qualitative study.
    Haynes SC; Pallin R; Tong K; Henderson S; Romano PS
    Heart Lung; 2020; 49(3):251-258. PubMed ID: 32087985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary Pressure Monitoring for Patients With Heart Failure.
    Wang JT; Frishman WH
    Cardiol Rev; 2017; 25(2):53-58. PubMed ID: 27465538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report on ambulatory pulmonary pressure monitoring: an attempt to reduce readmissions for heart failure with preserved ejection fraction.
    Angullo-Gómez M; Robles-Mezcua A; Becerra-Muñoz VM; García-Pinilla JM
    Eur Heart J Case Rep; 2022 Oct; 6(10):ytac401. PubMed ID: 36285229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Update of the Latest Evidence for CardioMEMS Pulmonary Artery Pressure Monitoring in Patients with Chronic Heart Failure: A Promising System for Remote Heart Failure Care.
    Brugts JJ; Radhoe SP; Aydin D; Theuns DA; Veenis JF
    Sensors (Basel); 2021 Mar; 21(7):. PubMed ID: 33801573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
    Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW;
    Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary artery pressure telemonitoring by CardioMEMS in a patient pre- and post-left ventricular assist device implantation.
    Veenis JF; Birim O; Brugts JJ
    Eur J Cardiothorac Surg; 2019 Oct; 56(4):809-810. PubMed ID: 30824913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study.
    García-González MJ; Aldea Perona A; Lara Padron A; Morales Rull JL; Martínez-Sellés M; de Mora Martin M; López Díaz J; López Fernandez S; Ortiz Oficialdegui P; Jiménez Sosa A
    ESC Heart Fail; 2021 Dec; 8(6):4820-4831. PubMed ID: 34716753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and feasibility of hemodynamic pulmonary artery pressure monitoring using the CardioMEMS device in LVAD management.
    Veenis JF; Radhoe SP; van Mieghem NM; Manintveld OC; Bekkers JA; Caliskan K; Bogers AJJC; Zijlstra F; Brugts JJ
    J Card Surg; 2021 Sep; 36(9):3271-3280. PubMed ID: 34159641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary Artery Pressure Monitoring Effectively Guides Management to Reduce Heart Failure Hospitalizations in Obesity.
    Brinkley DM; Guglin ME; Bennett MK; Redfield MM; Abraham WT; Brett ME; Dirckx N; Adamson PB; Stevenson LW
    JACC Heart Fail; 2021 Nov; 9(11):784-794. PubMed ID: 34509410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System.
    Schmier JK; Ong KL; Fonarow GC
    Clin Cardiol; 2017 Jul; 40(7):430-436. PubMed ID: 28272808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent levosimendan infusions in advanced heart failure: a real world experience.
    Ortis B; Villani A; Oldani M; Giglio A; Ciambellotti F; Facchini M; Parati G; Malfatto G
    J Int Med Res; 2017 Feb; 45(1):361-371. PubMed ID: 28222634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary Artery Proportional Pulse Pressure (PAPP) Index Identifies Patients With Improved Survival From the CardioMEMS Implantable Pulmonary Artery Pressure Monitor.
    Mazimba S; Ginn G; Mwansa H; Laja O; Jeukeng C; Elumogo C; Patterson B; Kennedy JLW; Mehta N; Hossack JA; Parker AM; Mihalek A; Tallaj J; Sodhi N; Kwon Y; Pamboukian SV; Adamson PB; Bilchick KC
    Heart Lung Circ; 2021 Sep; 30(9):1389-1396. PubMed ID: 33863665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
    Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
    JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter experiences with levosimendan therapy and its safety in patients with decompensated advanced heart failure.
    Lelonek M; Stopczyńska I; Korościk E; Straburzyńska-Migaj E; Gruchała M
    Adv Clin Exp Med; 2020 Nov; 29(11):1305-1312. PubMed ID: 33269816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.